 |
市場調查報告書
商品編碼
1378698
間質性膀胱炎治療藥物市場：依藥物類別、按類型、按給藥途徑、按配銷通路、按地區Interstitial Cystitis Drugs Market, By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計2023年全球間質性膀胱炎治療藥物市場將達2.349億美元，預測期內（2023-2030年）年複合成長率為6.9%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2022年 | 2023年市場規模 | 2.349 億美元 |
| 實績資料 | 2018-2021 | 預測期 | 2023-2030 |
| 預測期年複合成長率 | 6.90% | 2030年市場規模預測 | 3.756 億美元 |
圖 1. 2023 年間質性膀胱炎藥物的全球市場佔有率(%)（依藥物類別）
間質性膀胱炎（IC），也稱為膀胱疼痛症候群，是一種導致膀胱和骨盆周圍區域反覆不適和疼痛的疾病。即使是同一個人，症狀也因情況而異。您的膀胱和骨盆區域可能會感到輕微的不適、壓力、壓痛或劇烈疼痛。症狀包括迫切需要排尿、頻繁需要排尿或這些症狀的組合。當膀胱充滿尿液或排空時，疼痛的強度可能會改變。對於女性來說，月經期間症狀往往會惡化。您在陰道性交時也可能會感到疼痛。
在間質性膀胱炎或膀胱疼痛症候群中，膀胱壁會發炎，並且可能會出現疤痕或變硬。漢納潰瘍是膀胱壁上的皮膚破損斑塊，10% 的 IC 患者會出現這種情況。一些患有 IC 或 PBS 的人可能會發現他們的膀胱容納的尿液較少，並且排尿更頻繁。
市場動態
間質性膀胱炎患者治療的活性化預計將在預測期內推動市場成長。例如，2023年4月10日，瑞士洛桑大學醫院Center Hospitalier Universitaire Vaudois與瑞士伯爾尼大學醫院的研究人員合作，研究間質性膀胱炎和膀胱疼痛症候群，並宣布開始臨床研究評估術前口服免疫營養（IN）對病人術後併發症影響的試驗研究。該研究目前處於第三階段，正積極招募患者。
本次測試的主要特點
- 本報告對全球間質性膀胱炎治療藥物市場進行了詳細分析，並提出了以2022年為基準年的預測期（2023-2030）的市場規模和復合年度（年複合成長率）。
- 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
- 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
- 根據公司亮點、產品系列、主要亮點、業績和策略等參數對全球間質性膀胱炎治療藥物市場的主要企業進行了分析。
- 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
- 全球間質性膀胱炎治療藥物市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
- 透過用於分析全球間質性膀胱炎治療藥物市場的各種策略矩陣，將促進相關人員的決策。
目錄
第1章 研究目的與前提
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章 市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 市場機會
- 影響分析
- 最近的藥物上市以及歷史藍圖
- 流行病學
- 管道分析
- 收購與合作
- 法規場景
- 主要進展
- PEST分析
第4章 全球間質性膀胱炎治療藥物市場－COVID-19的影響分析
- 經濟影響
- COVID-19 的流行病學
- 對需求和供給的影響
第5章 全球間質性膀胱炎治療藥物市場，依藥物類別，2018-2030
- 非類固醇消炎劑
- 三環抗憂鬱藥物
- 戊聚醣多硫酸鈉（Elmiron）
- 二甲亞碸 (DMSO)
- 其他（抗組織胺等）
第6章 全球間質性膀胱炎治療藥物市場，依類型，2018-2030
- 非潰瘍性
- 潰瘍性的
第7章 全球間質性膀胱炎治療藥物市場，依給藥途徑，2018-2030
- 口服
- 膀胱內
第8章 全球間質性膀胱炎治療藥物市場，依配銷通路，2018-2030
- 醫院藥房
- 零售藥房
- 網路藥房
第9章 全球間質性膀胱炎治療藥物市場，按地區，2018-2030
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中東
- GCC
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第10章 競爭形勢
- 公司簡介
- AbbVie Inc.
- Hyloris Pharmaceuticals SA
- TAGCyx Biotechnologies
- KYORIN Pharmaceutical Co., Ltd.
- PureTech Health
- Vaneltix
- Red Leaf Medical Inc.
- Bayer AG
- Eli Lilly and Co.
- Johnson &Johnson（Janssen Pharmaceuticals）
- Mylan NV（Viatris Inc.）
- Perrigo Co. Plc
- Pfizer Inc.
- Seikagaku Corp.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- ImprimisRx（Harrow Health, Inc.）
第11章章節
- 參考
- 調查方法
簡介目錄
Product Code: CMI4488
The global interstitial cystitis drugs market is estimated to be valued at US$ 234.9 million in 2023 and is expected to exhibit a CAGR of 6.9% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 234.9 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 6.90% | 2030 Value Projection: | US$ 375.6 Mn |
Figure 1. Global Interstitial Cystitis Drugs Market Share (%), By Drug Class, 2023
Interstitial cystitis (IC), also known as painful bladder syndrome, is a condition that results in recurring discomfort or pain in the bladder and the surrounding pelvic area. The symptoms can differ between cases and even within the same person.People may experience mild discomfort, pressure, tenderness, or intense pain in the bladder and pelvic area. Symptoms may include an urgent need to urinate, a frequent need to urinate, or a combination of these symptoms. Pain may change in intensity as the bladder fills with urine or as it empties. Women's symptoms often get worse during menstruation. They may sometimes experience pain during vaginal intercourse.
In interstitial cystitis or painful bladder syndrome, the bladder wall may be irritated and become scarred or stiff. Hunner's ulcers, patches of broken skin found on the bladder wall, are present in 10 percent of people with IC. While some people with IC or PBS find that their bladder cannot hold much urine, which increases the frequency of urination.
Market Dynamics
Rising research and development activities for the treatment of patients suffering from interstitial cystitis are expected to propel market growth over the forecast period. For instance, on April 10, 2023, Centre Hospitalier Universitaire Vaudois, a university hospital in Lausanne, Switzerland, in collaboration with researchers of the University Hospital based in Bern, Switzerland, announced the initiation of a clinical trial study to evaluate the impact of preoperative oral immunonutrition (IN) on post-operative complications in patients undergoing interstitial cystitis and painful bladder syndrome, which is currently in phase 3 and actively recruiting patients.
Key features of the study:
- This report provides an in-depth analysis of the global interstitial cystitis drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global interstitial cystitis drugs market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AbbVie Inc., Hyloris Pharmaceuticals SA, TAGCyx Biotechnologies, KYORIN Pharmaceutical Co., Ltd., PureTech Health, Vaneltix, Red Leaf Medical Inc., Bayer AG, Eli Lilly and Co, Johnson & Johnson (Janssen Pharmaceuticals), Mylan NV (Viatris Inc.), Perrigo Co. Plc, Pfizer Inc., Seikagaku Corp., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and ImprimisRx (Harrow Health, Inc.)
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global interstitial cystitis drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interstitial cystitis drugs market
Interstitial Cystitis Drugs Market Detailed Segmentation:
- By Drug Class:
- Non-steroidal Anti-inflammatory Drugs
- Tricyclic Antidepressants
- Pentosan Polysulfate Sodium (Elmiron)
- Dimethyl Sulfoxide (DMSO)
- Others (Anti-histamines, etc.)
- By Type:
- Non-ulcerative
- Ulcerative
- By Route of Administration:
- Oral
- Intravesical
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
- Company Profiles
- AbbVie Inc.
- Hyloris Pharmaceuticals SA
- TAGCyx Biotechnologies
- KYORIN Pharmaceutical Co., Ltd.
- PureTech Health
- Vaneltix
- Red Leaf Medical Inc.
- Bayer AG
- Eli Lilly and Co.
- Johnson & Johnson (Janssen Pharmaceuticals)
- Mylan NV (Viatris Inc.)
- Perrigo Co. Plc
- Pfizer Inc.
- Seikagaku Corp.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- ImprimisRx (Harrow Health, Inc.)
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Drug Launch with Historic Roadmap
- Epidemiology
- Pipeline Analysis
- Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Interstitial Cystitis Drugs Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Interstitial Cystitis Drugs Market, By Drug Class, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Non-steroidal Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
- Tricyclic Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
- Pentosan Polysulfate Sodium (Elmiron)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
- Dimethyl Sulfoxide (DMSO)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
- Others (Anti-histamines, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
6. Global Interstitial Cystitis Drugs Market, By Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Non-ulcerative
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
- Ulcerative
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
7. Global Interstitial Cystitis Drugs Market, By Route of Administration, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
- Intravesical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
8. Global Interstitial Cystitis Drugs Market, By Distribution Channel, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
9. Global Interstitial Cystitis Drugs Market, By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/ Region, 2018-2030, (US$ Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- AbbVie Inc.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Hyloris Pharmaceuticals SA
- TAGCyx Biotechnologies
- KYORIN Pharmaceutical Co., Ltd.
- PureTech Health
- Vaneltix
- Red Leaf Medical Inc.
- Bayer AG
- Eli Lilly and Co.
- Johnson & Johnson (Janssen Pharmaceuticals)
- Mylan NV (Viatris Inc.)
- Perrigo Co. Plc
- Pfizer Inc.
- Seikagaku Corp.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- ImprimisRx (Harrow Health, Inc.)
11. Section
- References
- Research Methodology
- About us and Sales Contact
